Diseases and ConditionsNews - Page 1

NHS patients receive first home-grown blood plasma treatment

Discover more about how the UK has been building its own supply of blood plasma treatment amid a global shortage.

Transforming cancer care: MCTRC pioneers innovative research to bridge lab discoveries and patient treatment

McGill Centre for Translational Research in Cancer discuss the Centre’s essential role in advancing cancer research.

Strategising vaccine supply chains in developing countries

Learn more about the challenges and opportunities in optimising vaccine supply chains in developing countries such as Sierra Leone and Niger.

How diabetes fuels antibiotic resistance: What you need to know

Discover how diabetes accelerates antibiotic resistance, increasing the risk of untreatable infections. Find out more.

AI-powered breast cancer screening trial to revolutionise early detection in the UK

700,000 UK women will take part in the EDITH trial to test the effectiveness of AI in detecting breast cancer earlier. Find out more.

MHRA consults guidance on new personalised mRNA cancer vaccines

Individualised mRNA cancer vaccines are a new type of cancer treatment that uses mRNA technology. Discover more here.

How vaccines can improve cardiovascular health in the EU

The EU needs additional measures to address existing gaps and enhance the effectiveness of initiatives to improve cardiovascular health.

Oxford University to lead new centres tackling untreatable diseases

The two new research centres aim to develop advanced treatments for currently untreatable diseases. Discover more here.

AI blood test revolutionises early breast cancer detection

Discover how an AI blood test detects early-stage breast cancer with 98% accuracy, paving the way for personalised cancer screening.

Oncopole: Québec’s catalyst for cancer research and innovation

Oncopole drives cancer research in Québec, uniting partners to accelerate innovation in treatment, prevention, and patient care.

Sugemalimab approved to treat adult patients with non-small cell lung cancer    

The MHRA has approved the medicine sugemalimab (Eqjubi) to treat adult patients with non-small cell lung cancer. Read more here.

CMT Awareness Month: Raising awareness of a little-known condition

Many people are not aware of CMT disease, which can make everyday living and early medical diagnosis more difficult. Read more here.

The Université de Sherbrooke’s interdisciplinary approach for studying cancer in all its complexity

The Université de Sherbrooke's IRCUS is developing innovative interdisciplinary research to reduce the impact of cancer on affected people.

New saliva-based prostate cancer test could save NHS £500m

A revolutionary new prostate cancer test, which can be taken at home, could lead to thousands of earlier diagnoses for the NHS.

Innovation News Network - Free Digital eBook Library

Innovation News Network - Global Innovation Partners

Special Reports

Partner News

Special Reports Cont'd

Partner News Cont'd